ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025

ADMA Biologics (Nasdaq: ADMA) has announced its participation in the 43rd Annual J.P.

Rhea-AI Summary

ADMA Biologics (Nasdaq: ADMA) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The company's presentation is scheduled for Monday, January 13, 2025, at 10:30 a.m. PT.

As an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing, and developing specialty biologics, ADMA will make its presentation available through a live audio webcast accessible via the investor section of the company's website under 'Events & Webcasts'. An archived version of the webcast will be available approximately two hours after the event.

Argus Session date unavailable

-4.39% session move Open Argus

Details

News Market Reaction – ADMA

The recorded move for ADMA in the trading session of this news was -4.39%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RAMSEY, N.J. and BOCA RATON, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ADMA’s presentation will be on Monday, January 13, 2025, at 10:30 a.m. PT.

A live audio webcast of the call will be available under “Events & Webcasts” in the investor section of the Company’s website, https://ir.admabiologics.com/events-webcasts. An archived webcast will be available on the Company’s website approximately two hours after the event.

About ADMA Biologics, Inc. (ADMA)

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM^® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB^® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty biologics and human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA holds numerous U.S. and foreign patents related to and encompassing various aspects of its products and product candidates. For more information, please visit www.admabiologics.com.

INVESTOR RELATIONS CONTACT:
Argot Partners | 212-600-1902 | ADMA@argotpartners.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is ADMA Biologics presenting at the J.P. Morgan Healthcare Conference 2025?

ADMA Biologics is scheduled to present on Monday, January 13, 2025, at 10:30 a.m. PT at the J.P. Morgan Healthcare Conference in San Francisco.

How can investors watch ADMA Biologics' J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live audio webcast available in the 'Events & Webcasts' section of ADMA's investor relations website at https://ir.admabiologics.com/events-webcasts.

Will ADMA's J.P. Morgan Healthcare Conference presentation be available after the event?

Yes, an archived version of the webcast will be available on ADMA's company website approximately two hours after the presentation.

What is the duration of the 2025 J.P. Morgan Healthcare Conference where ADMA is presenting?

The 43rd Annual J.P. Morgan Healthcare Conference runs from January 13-16, 2025, in San Francisco, California.